Transferring a Validated Impurity Assay to a New CDMO

Challenge: A sponsor needed to transfer a validated residual Protein A ELISA to a new manufacturing CDMO ahead of a site change.

Approach: A transfer protocol with predefined acceptance criteria was developed, alongside comparability testing between sites.

Outcome: The receiving site met all acceptance criteria on first attempt, avoiding a repeat validation cycle.